Skip Navigation LinksHome > May 2012 - Volume 5 - Issue 5 > Clinical Trial Alert
Text sizing:
A
A
A
Nephrology Times:
doi: 10.1097/01.NEP.0000415396.87326.e9
Clinical Trial Alert

Clinical Trial Alert

Free Access

The following is a partial list of new clinical trials recently added to the National Institutes of Health's ClinicalTrials.gov online registry. More information on these trials is available at www.clinicaltrials.gov.

Back to Top | Article Outline

• Acute Kidney Injury •

NCT01560650

Effect of the Intensity of Continuous Renal Replacement Therapy in Patients with Acute Kidney Injury

Ages eligible for study: 18 years and older

Sponsors and collaborators: Wei Shi, Guangdong General Hospital

Contact: Wei Shi, MD, PhD

Phone: 86-20-83850849

E-mail: weishi_gz@126.com

NCT01557361

Standard Versus Accelerated Initiation of Dialysis in Acute Kidney Injury (STARRT–AKI)

Ages eligible for study: 18 years and older

Sponsors and collaborators: St. Michael's Hospital, Toronto; Canadian Institutes of Health Research; Alere San Diego

Contact: Karen L. Pope, MSc

Phone: 416-864-6060, ext. 7853

E-mail: popek@smh.ca

Contact: Judith Hall, MSc

Phone: 416-864-6060, ext. 7121

E-mail: hallju@smh.ca

NCT01573104

Evaluating Novel Biomarkers in Acute Kidney Injury

Ages eligible for study: 18 years to 90 years

Sponsors and collaborators: Dr. Robert Docking, University of Glasgow

Contact: Robert I. Docking, MBChB

Phone: 447717824350

E-mail: robert.iain.docking@gmail.com

Contact: John Kinsella, MD

Phone: 4411412114625

E-mail: john.kinsella@glasgow.ac.uk

NCT01573962

A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury

Ages eligible for study: 21 years and older

Sponsors and collaborators: Astute Medical

Contact: Karin Hughes, PhD

Phone: 858-882-0466

E-mail: khughes@astutemedical.com

NCT01582360

Pharmacokinetics of Anti-infectives/Antibiotics in Critically Ill Patients in Need of Continuous Renal Replacement Therapy

Ages eligible for study: 18 years and older

Sponsors and collaborators: Oslo University Hospital

Contact: Elin Helset, MD, PhD

Phone: +4722119585

E-mail: ehj@ous-hf.no

Back to Top | Article Outline

• Anemia •

NCT01587924

Four-Week Switch Study in Hemodialysis-Dependent Subjects with Anemia Associated with Chronic Kidney Disease

Ages eligible for study: 18 years and older

Sponsors and collaborators: GlaxoSmithKline, Pharmaceutical Product Development Clinical Research Organization

Contact: US GSK Clinical Trials Call Center

Phone: 877-379-3718

E-mail: GSKClinicalSupportHD@gsk.com

NCT01587898

Four-Week Correction Study in Subjects with Anemia Associated with Chronic Kidney Disease Who Are Not Undergoing Dialysis

Ages eligible for study: 18 years and older

Sponsors and collaborators: GlaxoSmithKline, Pharmaceutical Product Development Clinical Research Organization

Contact: US GSK Clinical Trials Call Center

Phone: 877-379-3718

E-mail: GSKClinicalSupportHD@gsk.com

NCT01581073

Prevention of End-Stage Kidney Disease by Darbepoetin Alfa in Chronic Kidney Disease Patients with Nondiabetic Kidney Disease (PREDICT)

Ages eligible for study: 20 years to 85 years

Sponsors and collaborators: Translational Research Informatics Center, Kobe, Hyogo, Japan; Showa University School of Medicine

Contact: Enyu Imai, MD, PhD

Phone: +81-52-744-2192

E-mail: imai@med.nagoya-u.ac.jp

Back to Top | Article Outline

• Chronic Kidney Disease–Mineral and Bone Disorder •

NCT01561222

Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients with Chronic Kidney Disease Stage 1 and 2

Ages eligible for study: 18 years to 80 years

Sponsors and collaborators: Taixing People's Hospital

Contact: Xu Zhang

Phone: 008-613-905-266-789

E-mail: dr.zhangxu@tom.com

Contact: Cai-xia Zhao

Phone: 008-615-896-079-628

E-mail: zhaocaixia2010@yahoo.cn

NCT01574326

An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Patients with Chronic Kidney Disease

Ages eligible for study: 18 years and younger

Sponsors and collaborators: Genzyme

Contact: Medical Information

Phone: 800-745-4447

E-mail: medinfo@genzyme.com

NCT01554982

A Long-Term Safety Extension Trial of Ferric Citrate in Patients with End-Stage Renal Disease (ESRD) on Dialysis

Ages eligible for study: 18 years and older

Sponsors and collaborators: Keryx Biopharmaceuticals

Contact: Mohammed Sika, PhD

E-mail: mohammed.sika@vanderbilt.edu

Back to Top | Article Outline

• Contrast-Induced Acute Kidney Injury •

NCT01562925

Effect of Red Wine, White Wine, and Beer on Contrast Medium-Induced Acute Kidney Injury (RenPro-II-WINE)

Ages eligible for study: 18 years and older

Sponsors and collaborators: University of Cologne

Contact: Fikret Er, MD

Phone: +4922147832544

E-mail: fikret.er@uk-koeln.de

Contact: Natig Gassanov, MD

Phone: +4922147832354

E-mail: natig.gassanov@uk-koeln.de

Back to Top | Article Outline

• End-Stage Renal Disease •

NCT01562340

Pomegranate and Hemodialysis Pilot Trial (POM Pilot)

Ages eligible for study: 18 years to 85 years

Sponsors and collaborators: University of Washington

Contact: Lori Linke

Phone: 206-616-8574

E-mail: lori.linke@nwkidney.org

Contact: John Kundzins

Phone: 206-616-8574

E-mail: info@kri.washington.edu

NCT01561118

DiaSport: Endurance-Orientated Training Program with Children and Adolescents on Maintenance Hemodialysis

Ages eligible for study: 6 years to 19 years

Sponsors and collaborators: University of Cologne, German Sport University Cologne, Hannover Medical School

Contact: Bernd Hoppe, MD

Phone: +49-221-478, ext. 6831

E-mail: bernd.hoppe@uk-koeln.de

Contact: Markus Feldkötter, MD

Phone: +49-221-478, ext. 6831

E-mail: markus.feldkoetter@uk-koeln.de

Back to Top | Article Outline

• Hypertension •

NCT01560312

Renal Denervation in Refractory Hypertension (PRAGUE-15)

Ages eligible for study: 18 years and older

Sponsors and collaborators: Charles University, Czech Republic; University Hospital Olomouc; Cardiocenter Podlesí, Trinec, Czech Republic

Contact: Petr Widimsky, MD

Phone: 00420267163159

E-mail: petr.widimsky@fnkv.cz

NCT01549444

Renin and Aldosterone Levels in the Preterm Neonate at Risk for Hypertension

Ages eligible for study: 26 weeks to 34 weeks

Sponsors and collaborators: Ottawa Hospital Research Institute, Physicians' Services Incorporated Foundation

Contact: Erika Bariciak, MD

Phone: 613-737-7600, ext. 2954

E-mail: bariciak@cheo.on.ca

Contact: Brigitte Lemyre, MD

Phone: 613-737-8899, ext. 71882

E-mail: blemyre@ottawahospital.on.ca

© 2012 Lippincott Williams & Wilkins, Inc.

Login